<<

4/23/2015

ECMO Strategies for Refractory Respiratory Failure: The Who, How and Why

Christine Lasich RN, BSN, CCRN Randall/Emanuel Severe Cardio-pulmonary Failure and ECMO (RESCUE) Center.

The Extracorporeal Life Support Organization 2013 Award for Excellence in Life Support

www.ELSO.org  Demonstrates High quality standards Specialized equipment and supplies Defined patient protocols Advanced education of all staff members

NO DISCLOSURES

 No financial relationships to disclose

 Any reference to a specific brand or product is not intended as an endorsement, but rather a reflection of the device or product with which we are familiar.

1 4/23/2015

OBJECTIVES

 Describe the clinical indications for ECMO support and discuss how ECMO supports oxygenation and ventilation

 Describe actions required to prepare a patient for initiation of ECMO

 Identify the unique multisystem nursing considerations for adult patients on ECMO

The ECMO team Clinical Administration

 Nursing – Bedside  ECMO Manager  Nursing – ECMO Specialist  ECMO Director  Perfusionist ECMO Coordinator  Respiratory Therapist   Physician  Registrar  Surgeon  PI Coordinator  Critical Care   ECMO Bedside Educator  Palliative Care/Social Worker  ECMO Specialist Educator  PT/OT/Speech Therapy  Dietitian

Extracorporeal Membrane Oxygenation (ECMO): What?

 Mechanical cardiopulmonary or pulmonary support

 May be configured Venoarterial (VA) or Venovenous (VV)

 Lungs no longer primary site of oxygenation and ventilation

2 4/23/2015

The Cannulas

The Pump Centrifugal pumps

 Most prevalently used

 Improved performance with less complications

 Preload and afterload dependent

The Oxygenator

 Hollow fibers (<0.5mm in diameter) coated with polymethylpentene  Allow diffusion of gas but not liquid.  As blood flows through the oxygenator, “sweep gas” (oxygen) is piped through the inside of the hollow fibers

 Oxygen and CO2 diffuse across membrane

3 4/23/2015

The Circuit

ECMO: How? Physiology of Extracorporeal Support It comes full circle… Flow and Sweep

Blood returned to  Flow = quantity of blood patient via Drainage via “arterial” venous delivered (L/min) cannula cannula  Sweep = Flow rate of oxygen from blender to oxygenator

Flow Flow O2 Blood maintained by warmed to centrifugal normothermia pump

Oxygen and Sweep CO ventilation via 2 membrane oxygenator

ECMO CIRCUITS Rotoflow

Cardiohelp

4 4/23/2015

Anatomy of an ECMO Circuit

 Essential Components:  Cannulas Display: SVO2, Hct Venous drainage and Hgb from  Tubing tubing: venous sensor Deoxygenated  Pump blood draining from the patient.  Oxygenator Console Arterial Blood Return  Gas Blender Tubing: Oxygenated Blood returning to the Heat Exchanger  Heat exchanger patient.  “Bridge” Oxygenator Bridge  O2 Sat measurement Centrifugal Pump  Bubble detectors Venous Oxygen Sensor  Monitors and alarms

The artificial endothelium aka – the ECMO circuit

ECMO and

Anticoagulation Oxygenator is essential to prevent clotting in the ECMO circuit

This makes Centrifugal bleeding the pump #1 risk factor related to ECMO

5 4/23/2015

Extracorporeal Membrane Oxygenation (ECMO)

Does not “cure” anything

It takes over the work of the heart or lungs while they heal

ECMO: Why?

Improving efficacy and outcomes with advent of new technology Increasing patient volumes = more experience = more informed practice

Conventional Ventilation of ECMO for Severe Adult Respiratory Failure (CESAR)  180 patients randomized to either Kaplan-Meier survival estimates, by allocat conventional management group or consideration for ECMO treatment. 63 %  Eligible patients had potentially reversible respiratory failure and 47% met strict entry criteria.  Findings: 6 month survival rate 63% versus 47% for control group.

50 100 150 Analysis time (days)

Conventional ECMO

Noah et al.JAMA 2011. Peek Lancet. 2009

6 4/23/2015

EOLIA trial  ECMO to rescue lung injury in severe ARDS (EOLIA)  Ongoing international randomized controlled trial  Daniel Brodie

ECMO: Where? Regional Referral Program  ECMO care requires a trained, multidisciplinary team  ECMO patients have improved outcomes when cared for at experienced, high volume centers “..., advanced critical care for profound ARDS, including ECMO, represents the type of time- dependent and high-reliability practice that might best be provided in a focused setting in which the provider and systems aspects of performance would benefit from a high density of experience.” Michaels et al. (2013)

Why Transfer?

 CESAR TRIAL: “We recommend transferring of adult patients with severe but potentially reversible respiratory failure, …, to a center with an ECMO-based management protocol to significantly improve survival without severe disability.” - Peek et al. 2009

 JAMA: “For patients with H1N1-related ARDS, referral and transfer to an ECMO center was associated with lower hospital mortality compared with matched non– ECMO-referred patients.” – Noah et al. 2011

7 4/23/2015

Who Needs ECMO?

• Refractory ARDS • Pneumonia • Sepsis • Severe respiratory failure • Shock • Near Drowning • Bridge to transplant • Trauma

ECMO Contraindications ** All Contraindications are relative **  Related to patient’s premorbid condition:  Age and size  Contraindication to anticoagulation  Chronic condition associated with poor outcome  Underlying terminal condition not related to ARDS  Limitations to care (code status)  Related to treatment of current illness:  Greater than 7 - 10 days on mechanical ventilator with

peak airway pressure > 30 cmH2O and/or FiO2 > 0.8 ** Must have an endpoint to care **

8 4/23/2015

VA vs VV ECMO

CARDIAC FAILURE PULMONARY FAILURE VenoArterial VenoVenous

VenoArterialECMO Cardiac

 May be applied for management of cardiac and/or respiratory failure  Blood access via central and central artery, primarily femoral  Controls up to 80% of patient’s total cardiac output (CO)

VenoArterialECMO Indications

 Patients who cannot wean from cardiac bypass

 Refractory cardiogenic shock

o Bridge to VAD o Bridge to transplant o ECPR

Must have endpoint to care

9 4/23/2015

VenoVenousECMO Respiratory

 Provides pulmonary support only

 Relies on the patient’s native heart function to circulate the newly oxygenated blood

 “IV Oxygen”

 Blood access via femoral and / or internal jugular vein

H CTA CHEST/ABDOMEN/PELV VenoVenousECMO 11/ Indications

 Severe Refractory Respiratory Failure from potentially reversible cause.

 Type I (Hypoxemic) Respiratory Failure (severe) with P:F <80 on FiO2 >90% with a Murray lung A CTA CHEST WWO + ABDOMEN/PELVIS W CONTRAST 6/1/1959 CTA CHEST 125mL iso 370 dws 53 YEAR 2/2/20132/2/2013 3:16:01 AM F 20930779 injury score of ≥ 3.0. APPLIEDAPPLIED LOC: -996.20-996.20 THK: 2 HFS  Type II (Hypercapnic) Respiratory Failure with a pH ≤ 7.2. R L

RD: 400 Tilt: 0 Z: 1 mA:mA : 56456 4 C: -585 KVKVp:p: 140 W: 1800 Acq no: 10 DFOV:40x40cmDFOV:40x40cm Compressed 7:1 PaPage:ge: 6969 ofof 121 P IIM: M : 669 9 SESE: : 55 cmcm

Acute Respiratory Distress Syndrome (ARDS)  No effective pharmacological treatment

 Cornerstone to therapy remains supportive care with mechanical ventilation

 ARDS Network recommendations for volume and pressure limited ventilation strategies associated with decreased mortality

 Despite ARDSnet strategy, some patients continue to decline

10 4/23/2015

Current definition of ARDS aka, the “Berlin Definition”:

 Mild ARDS (PaO2 to FiO2 ratio 200 – 300) 20 mortality: 27%

 Moderate ARDS (PaO2 to FiO2 ratio 100 – 200) mortality: 32%

 Severe ARDS (PaO2 to FiO2 ratio < 100) mortality: 45%

28% of all ARDS is “severe”

ARDS Definition Task Force, Raneri VM, Reubenfeld GD, et al: Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012 Jun 20;307(23):2526-33

ECMO: When? Hypoxia becomes refractory to conventional management

 Recruitment maneuvers  Neuromuscular blockade  Inhaled NO / EPO  Prone Positioning  APRV  HFOV / HFPV  ECMO

NEED FOR VENILATORY ALI/ARDS Inclusion Criteria SUPPORT PaO2/FiO2 <300 (ALI) PAO2/FiO2 <200 (ARDS) Yes Bilateral Infiltrates Recruitment Maneuver No LA Hypertension Must be approved by physician Acute Onset Conventional CPAP 40 cmH2O for 40 sec No LA Hypertension Ventilation with -OR- ARDSnet Strategy eSIGH with PEEP 10cm above LIP set PEEP above Lower Inflection Point at end of maneuver Consider CT scan: evaluate for reversible issues Consider for Recruitment Maneuvers Optimize Cardiovascular Status/Swan-Ganz prn Address anatomical issues: PTX, effusions, etc Evaluate for Proning, Paralytics, Nitric Oxide

Assessment of Patient Improvement: Yes Continue P:F ratio >200 ARDSnet On FiO2 < 70% and PEEP < 12 Consider Initial use of VDR for: Strategy  Pregnant or obese patient Meeting Ventilation Goals pH >7.25  Inhalation injury  Massive Secretions/Lobar No collapse  Status Asthmaticus Place on APRV  Massive Air leak Consider Consultation or Transfer

Continue Yes Assessment of Patient Improvement APRV No Place on HFOV (or VDR) Consider Transfer

Yes Continue Assessment of Patient Improvement HFOV/VDR See selection criteria – Table 1 No Consider ECMO Transfer

11 4/23/2015

KEY POINTS

 Increased ventilator days and high ventilator settings are associated with higher mortality.

 Preferred fewer than 7 intubated days

 The longer the patient has been sick, the longer they will be on ECMO.

Early referral saves lives!

Before going on ECMO

 Baseline labs  **Type and Crossmatch**  Hct and coags  Anticipate fluid / blood volume resuscitation  Place all lines and tubes prior to initiation of anticoagulation  Central Lines  Peripheral IV  Foley Catheter  Feeding tube

Transformation

Intensive Care to Operating Room

12 4/23/2015

COMMUNICATION

 Blood bank  Respiratory Therapy  Pharmacist  Operating Room staff  X-Ray  Family

Supplies

Anticoagulation

 Heparin Monitoring for effect:  ACT (goal ~1.5x normal, 180-220 seconds)  Heparin level (0.2-0.4)  Optimize AT III (>80)  Direct Thrombin Inhibitors  Argatroban  Bivalirudin  PTT (45-75)

13 4/23/2015

Cannulation: Going on ECMO  May be performed in ICU or OR

 Full sterile prep and OR team present

 Deep sedation / paralysis essential

 Heparin bolused (50-100 units / kg) prior to cannula placement

 Coordination between surgeon, perfusion and bedside RNs This is a critical time. The room needs to be quiet for clear communication

And we’re on….

 ECMO flow slowly increased to maximum tolerated, then decreased to lowest level required for adequate support.

 Sit back and watch the red blood flow…

What could go wrong?

Patient is bolused with approximately 1liter of saline from ECMO circuit This essentially empties blood from the heart temporarily

14 4/23/2015

Code situations Bedside Nurse Manages the Patient

Full ventilator support Titrate vasoactive drugs May need blood and products Prepare code cart and ACLS drugs May need to emergently switch to VA

Complications

Vessel injury Thrombus

Lung injury

Equipment Malfunction

Occurs less than 5% Air emboli

Emergencies

15 4/23/2015

Bleeding Emergencies

• Time to call the blood bank

• Know your institution’s resources and policies

ECMO is initiated Oxygenation improves immediately

 Perfusion improved  Myocardial function improved  Pulmonary pressures decrease  Wean inotropes and vasoactive drips  Rest settings on ventilator

Diagnostic Procedures

Labs ABG guides ECMO therapy PTT 45-75 Chest X-ray Cannula placement Occasional tests Echocardiogram EKG Ultrasound CT

16 4/23/2015

Multisystem care of the ECMO patient

 Cardiovascular / Hemodynamic  Respiratory  Hematologic Considerations  Neurologic / Sedation  Renal  Metabolic / Gastrointestinal  Skin  Family  Recovery vs. Futility  Decannulation

Cardiovascular and Hemodynamic Considerations  VV: Pt. dependent on native hemodynamic physiology  Support with inotropes, vasoactives, fluid, blood etc. as indicated  MAP >65  VA: ECMO flow provides primary hemodynamic support  May require fluid / blood / vasopressors to augment  Maintain MAP 50-70

Additional Hemodynamic Considerations

 Trend markers of perfusion / native heart function  Lactate  ABGs

 SvO2  Continuous pulse contour analysis (PiCCOTM, FloTracTM) – VV only  Echocardiography  Urine output, skin color/temp, cap refill, etc.  Pulmonary artery catheters?  Pt. temp controlled by heat exchanger

17 4/23/2015

Treating the Underlying Problem  Infection  Abx  Antiviral therapy (H1N1)

 Inflammation  Plasmapharesis  IVIG  Trauma  Surgical repair

*Infectious Disease and input is crucial*

Respiratory Considerations  The lungs are no longer the primary site of oxygenation and ventilation!!!

 3 R’s  Rest  Recover  Recruit

Rest  Reducing pressure and FiO2

 ELSO Recs: Mode: pressure control FiO2: 0.3 PEEP: 10-15 cmH2O PIP: ~20 (PEEP + 10) F: 4-5  LEH: Mode: Volume Diffusive Respirator (VDR) FiO2: 0.4 PEEP: 12* PIP: 24* F: 15 Percussive Rate = 500  Other: CPAP, MMV, Extubation?

* VDR settings: PEEP = Oscillatory PEEP; PIP = Pulsatile Flow

18 4/23/2015

What is the VDR? A pneumatically powered, pressure limited, time-cycled, high frequency flow interrupter.

Delivers smaller, percussive tidal volumes at rates that range between 300-700 oscillations per minute at lower pressures.

Enhances oxygenation, promotes

CO2 clearance and facilitates mobilization of secretions while minimizing barotrauma

Increased secretion clearance necessitates vigilant oral care and secretion maintenance by RN staff

* Kunugiyama SK, Schulman CS. High-Frequency percussive ventilation using VDR-4 ventilator: an effective strategy for patients with refractory hypoxemia. AACN Advanced Crit Care. 2012;23(4):370-389

Recruit  Recruitment maneuvers  Positional Therapy  Bronchoscopy  Aggressive diuresis  Ventilator recruitment maneuvers  Initiated once lungs begin to show recovery

Additional Respiratory Considerations

 Pulmonary Hypertension Management  IV agents: Epoprostenol (Flolan), Nitroglycerin  Inhaled agents: Nitric Oxide, Epoprostenol  Tracheostomy  Pneumothorax (To drain or not to drain?)

19 4/23/2015

Hematologic Considerations  Systemic anticoagulation essential  Bleeding is a major complication of ECMO  Visible versus occult  Common bleeding sites:

Intracranial Mucous membranes Cannulation Sites Central lines and PIVs Surgical sites GI Tract

 **ICH on ECMO usually extensive and fatal**  Minimize Hemolysis  Monitor Plasma Free Hgb

Bleeding Management (Focus on prevention)

 Vigilant monitoring  studies  Plts, PT/INR, Fibrinogen, Viscoelastography (TEG™ / Rotem™)  Cannula sites, IVs, mucous membranes, neuro exam  Maintain Coagulation factors at acceptable levels  Platelets ≥ 50,000*  INR ≤ 2.2  Fibrinogen ≥ 100,000  Minimize venipuncture, fingersticks, insertion of tubes/drains, etc.

When Intervention is Required: (Bleeding Management continued)

 Return coagulation status to normal  D/C infusion (if necessary)  Thrombostatic dressings  OR as last resort

20 4/23/2015

Neurologic Considerations

 Maintain sedation and analgesia with least amount required to provide effective support & maintain safety

 Daily awakening trials as soon as tolerated  Neuromuscular blockade?

**Note: Some medications shown to have increased adsorption to circuit and oxygenator**

Neuro Assessment  Sedated and paralyzed?  Hourly pupil response assessment  Train of four  Low threshold for Head CT with neuro change

 Pupilometry  Near Infrared Spectroscopy (NIRS)

 Bispectral index monitor (BIS)

Renal Considerations

 Euvolemia is the goal  Diurese aggressively  Hemofiltration  CRRT if necessary  Directly into circuit  HD Catheter

21 4/23/2015

Gastrointestinal / Metabolic Considerations  Place post-pyloric feeding tube pre-ECMO if possible  Early consult from dietician  Enteral nutrition as soon as tolerated  TPN until tube feed tolerated at goal rate  Probiotic supplements  GI continuity  Stress ulcer prevention  Blood glucose management per hospital critical care insulin management protocol

Skin Care Considerations

 Eyes  Mucous membranes  Blisters  Pressure points  Q 2 hour turning and ROM essential  Continence management

Family Care Considerations  Include family as much as possible  Allow family presence in rounds  Include in plan of care  Honest and direct communication  Early palliative care consult

22 4/23/2015

Futility

 Possibility of stopping for futility should be discussed with family at outset of therapy

 Promptly discontinue ECLS when there is irreversible organ damage and no option for transplant

 Definition of irreversible damage depends on the institution and available resources

 Arbitrary timeframes for recovery are discouraged

Signs of Recovery

 Hemodynamic stability  Patient tolerates decreasing ECMO Flow and Sweep

 Evidence of clearing on CXR and bronchoscopy

 Pulmonary “step-up”

Trial off  VV:  Wean flow and sweep to minimal settings  Set ventilator to acceptable settings  “cap off” oxygenator

 Maintain ECMO blood flow while monitoring SaO2, PO2 and CO2.  VA:  Reduce flow.  Clamp access and return lines

 Monitor SaO2, PO2 and CO2.  If VA for cardiac support, ECHO very helpful

23 4/23/2015

Decannulation  May be performed at bedside if vascular repair not required

 Anticoagulant off for 30-60 minutes  Get “comfortable”

Program Considerations

 Education and team maintenance

 Intra-hospital Transport

 Inter-hospital Transport

ECMO Education and Team Maintenance  Formal ECMO education process  ECMO handbook for bedside nurses  Skills, drills, simulation, lecture, online SLMs  Collaborate with Pt. care champions  Additional mandatory CEUs Simulation Lab  Roles  Bedside RNs  Transport RNs  ECMO Specialists

24 4/23/2015

Intra-hospital Transport • Have a plan • Bedside RN is the team leader • Clear hallways • Coordinate with receiving department

Inter-hospital Transport

25 4/23/2015

For additional information:

www.elso.org

References Annich,., G.M., Lynch., W.R., MacLaren, G., Wilson, J.M., Bartlett, R.H. (2012). ECMO Extracorporeal Cardiopulmonary Support in Critical Care (4th ed.). Ann Arbor, MI: Extracorporeal Life Support Organization.

ARDS Definition Task Force, Ranieri V.M., Rubenfeld, G.D., et al. (2012). Acute respiratory distress syndrome: the Berlin definition. JAMA 307 2526-2533

Bibro C, Lasich C, Rickman R, et al. Critically ill patients with H1N1 influenza A undergoing extracorporeal membrane oxygenation. Crit Care Nurse. 2011;31:e8-e24

ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support Extracorporeal Life Support Organization, Version 1.3 November 2013 Ann Arbor, MI, USA www.elsonet.org

ELSO Adult Respiratory Failure Supplement to the ELSO General Guidelines Version 1.3 December 2013 Ann Arbor, MI, USA www.wlsonet.org

Holleran, R. (2010). ASTNA: Patient Transport, principles and practice (4th ed). Mosby, INC.

Michaels, A.J., Hill, J.G., & Long,., W.B., Young, B.P. Sperley, B.P., Shanks, T.R., Morgan, L.J. (2013). Adult refractory hypoxemic acute respiratory distress syndrome treated with extracorporeal membrane oxygenation: the role of a regional referral center. The American Journal of Surgery,205(), 492-499

Noah MA, Peek GJ, Finney SJ, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A (H1N1). JAMA 2011;306:1659-1668

Peek GJ, Mugford M, Tiruviopati R, et al. Efficacy and economic assessment of conventional ventilator support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicenter randomized controlled trial. Lancet. 2009;374(9698):1351-1363

26 4/23/2015

Christine Lasich, RN, BSN, CCRN Legacy Emanuel Hospital [email protected]

Thank you!

27